立即開始
Gilead Sciences, Inc.

GILD range bound, unlikely to break-out

由Fundamentals500提供
GILD

Remdesivir may help GILD breakout from multi-year range-bound pattern, however giving the limited income from it in the short-term, I would reckon we don't break out.
Fundamental AnalysisSupport and ResistanceTrend Analysis
Fundamentals500

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。